Lymphoma and Epstein-Barr virus DNA in blood during interleukin-2 therapy in antiretroviral-naïve HIV-1-infected patients: a substudy of the ANRS 119 trial.

HIV/IL-2 and EBV-associated lymphoproliferative diseases: cause and effect or coincidence? HIV Med (2014) 0.75

Interleukin-2 therapy in patients with HIV infection. N Engl J Med (2009) 4.38

Detection of human herpesvirus 8 and human T-cell lymphotropic virus type 1 sequences in Kaposi sarcoma. Arch Dermatol (1997) 2.71

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study. J Clin Oncol (2000) 2.30

HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet (1994) 2.25

Long-term follow-up of non-HIV Kaposi's sarcoma treated with low-dose recombinant interferon alfa-2b. Arch Dermatol (1996) 2.23

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study. Lancet (2013) 2.23

env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol (2000) 2.17

Genetic diversity and HIV detection by polymerase chain reaction. Lancet (1995) 2.03

Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol (1995) 1.99

Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol (2001) 1.96

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood (2000) 1.86

Is sclerosing angiomatoid nodular transformation (SANT) of the splenic red pulp identical to inflammatory pseudotumour? Report of 16 cases. Histopathology (2008) 1.82

Human herpesvirus 8-associated hemophagocytic lymphohistiocytosis in human immunodeficiency virus-infected patients. Clin Infect Dis (2003) 1.72

Structural brain changes in tinnitus. Cereb Cortex (2005) 1.71

Stromal cells from human long-term marrow cultures are mesenchymal cells that differentiate following a vascular smooth muscle differentiation pathway. Blood (1993) 1.71

Kaposi sarcoma-associated herpes-like virus (human herpesvirus type 8) DNA sequences in multicentric Castleman's disease: is there any relevant association in non-human immunodeficiency virus-infected patients? Blood (1996) 1.66

Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA). Blood (1998) 1.65

Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol (1997) 1.64

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome. AIDS (2004) 1.63

Destructive arthropathy in chondrocalcinosis articularis. Arthritis Rheum (1976) 1.63

Human herpesvirus 8 (HHV8) transmission and related morbidity in organ recipients. Am J Transplant (2012) 1.53

Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis (2000) 1.52

Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst (2000) 1.51

Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood (1997) 1.48

Pityriasis rosea and human herpesvirus 7, a true association? Dermatology (1998) 1.44

NMR evidence for gapped spin excitations in metallic carbon nanotubes. Phys Rev Lett (2005) 1.44

Acute rhabdomyolysis in patients infected by human immunodeficiency virus. Neurology (1994) 1.43

Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS (1996) 1.42

HIV-1 group O infection in Cameroon, 1986 to 1998. Emerg Infect Dis (2001) 1.41

HIV-1 subtypes and plasma RNA quantification. AIDS (1999) 1.40

Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france. Virology (2001) 1.40

Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from two patients with Sjögren's syndrome. Arthritis Rheum (1993) 1.40

Neurologic manifestations of essential thrombocythemia. Ann Intern Med (1983) 1.39

Observation of an antimatter hypernucleus. Science (2010) 1.38

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients. J Clin Oncol (1996) 1.37

Phylogenetic analysis of 49 newly derived HIV-1 group O strains: high viral diversity but no group M-like subtype structure. Virology (2002) 1.34

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte. Ann Oncol (2000) 1.34

Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors. AIDS (1998) 1.33

Serological and virological characterization of HIV-1 group O infection in Cameroon. AIDS (1997) 1.33

Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood (1993) 1.33

Breast cancer molecular subclassification and estrogen receptor expression to predict efficacy of adjuvant anthracyclines-based chemotherapy: a biomarker study from two randomized trials. Ann Oncol (2007) 1.29

Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. J Clin Microbiol (2005) 1.29

Imported human African trypanosomiasis in Europe, 2005-2009. Euro Surveill (2009) 1.28

Varicella in patients infected with the human immunodeficiency virus. Arch Dermatol (1990) 1.28

Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study. Am J Surg Pathol (1996) 1.27

Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility. J Virol (1998) 1.27

Surveillance of listeria infections in Europe. Euro Surveill (2005) 1.26

[Destructive arthropathies in chondrocalcinosis]. Rev Rhum Mal Osteoartic (1973) 1.26

Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22

Dengue type 3 virus infections in European travellers returning from the Comoros and Zanzibar, February-April 2010. Euro Surveill (2010) 1.22

HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. AIDS (2000) 1.21

First secondary case of Ebola outside Africa: epidemiological characteristics and contact monitoring, Spain, September to November 2014. Euro Surveill (2015) 1.20

Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood (1997) 1.19

Quantification of proviral load of human immunodeficiency virus type 2 subtypes A and B using real-time PCR. J Clin Microbiol (2001) 1.19

Molecular epidemiology of human herpesvirus 8 in africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread. Virology (2000) 1.18

[The unexpected Chikungunya outbreak]. Rev Med Interne (2006) 1.17

Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17

Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology (2001) 1.16

Genetic variability and integration of Merkel cell polyomavirus in Merkel cell carcinoma. Virology (2012) 1.16

Lymphangiohemangioma of the mediastinum. Ann Thorac Surg (1997) 1.14

Does triple-negative phenotype accurately identify basal-like tumour? An immunohistochemical analysis based on 143 'triple-negative' breast cancers. Ann Oncol (2007) 1.14

HIV-1 group N among HIV-1-seropositive individuals in Cameroon. AIDS (2000) 1.12

Multicentric evaluation of a new commercial cytomegalovirus real-time PCR quantitation assay. J Virol Methods (2007) 1.11

The MAL gene is expressed in primary mediastinal large B-cell lymphoma. Blood (1999) 1.11

Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test. J Virol Methods (2000) 1.10

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (1997) 1.10

Severe chloroquine-resistant falciparum malaria in Gabon with decreased sensitivity to quinine. Trans R Soc Trop Med Hyg (1986) 1.07

HIV-1 and HIV-2 AIDS in African patients living in Paris. AIDS (1997) 1.07

Absence of human herpesvirus 8 sequences in prostate specimens. AIDS (1997) 1.07

Immunohistochemichal expression of biomarkers: a comparative study between diagnostic bronchial biopsies and surgical specimens of non-small-cell lung cancer. Ann Oncol (2007) 1.07

Elderly patients with aggressive non-Hodgkin's lymphoma: disease presentation, response to treatment, and survival--a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J Clin Oncol (1997) 1.06

Clinical characteristics of the smooth tubercle bacilli 'Mycobacterium canettii' infection suggest the existence of an environmental reservoir. Clin Microbiol Infect (2010) 1.06

Long-term remission of an AIDS-related primary effusion lymphoma with antiviral therapy. AIDS (2001) 1.06

A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients. Hematol J (2001) 1.06

Precision measurement of charged pion and kaon differential cross sections in e+ e- annihilation at sqrt[s]=10.52  GeV. Phys Rev Lett (2013) 1.06

The expression of 16 genes related to the cell of origin and immune response predicts survival in elderly patients with diffuse large B-cell lymphoma treated with CHOP and rituximab. Leukemia (2008) 1.05

Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay. Clin Vaccine Immunol (2006) 1.05

Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses. J Infect Dis (1995) 1.04

Fatal acute melioidosis in a tourist returning from Martinique Island, November 2010. Euro Surveill (2011) 1.04

Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy. J Invest Dermatol (2001) 1.03

HIV-1 detection in cervicovaginal secretions during pregnancy. AIDS (1997) 1.01

HIV-1 group O sensitivity to antiretroviral drugs. AIDS (1995) 1.01

Study of e+ e- → π+ π- J/ψ and observation of a charged charmoniumlike state at Belle. Phys Rev Lett (2013) 1.01

Platelet factor 4 inhibits human megakaryocytopoiesis in vitro. Blood (1990) 1.01

Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials. Leukemia (2003) 1.00

Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d' Ile de France (GCIF). Transplantation (1999) 1.00

Vertical transmission of HIV-2. Lancet (1990) 1.00

No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr (2001) 0.99

Clonality analysis of hematopoiesis in essential thrombocythemia: advantages of studying T lymphocytes and platelets. Blood (1997) 0.99

[Risk of nosocomial infection in intertropical Africa--part 3: health care workers]. Med Trop (Mars) (2007) 0.98

Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J Clin Microbiol (1992) 0.98

Trypsin-treated Ma-104: a sensitive cell line for isolating enteric viruses from environmental samples. Appl Environ Microbiol (1984) 0.98

Essential role of choline for pneumococcal virulence in an experimental model of meningitis. J Intern Med (2008) 0.97

Therapeutic outcome and prognostic factors of invasive aspergillosis in an infectious disease department: a review of 34 cases. Infection (2008) 0.97

[Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over]. Rev Epidemiol Sante Publique (2010) 0.97

Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer. Ann Oncol (2007) 0.97

Lymphatic drainage of heart and lungs: comparison between pig and man. Surg Radiol Anat (2000) 0.97

SIVcpz from a naturally infected Cameroonian chimpanzee: biological and genetic comparison with HIV-1 N. J Med Primatol (2000) 0.97

HIV testing: reduce costs by all means, but not at all costs. Lancet (1993) 0.96